top of page
JPEG format LBV.jpg
header linkedin 2.png

 New Ways To Develop Medecines

Landmark BioVentures (LBV) is a global hub-and-spoke biotech company that creates new ways to develop medicines serving patients who suffer from life-threatening diseases.

Created in 2021 and headquartered in Basel (Switzerland), LBV has already built from scratch a nexus of biotech companies developing first-in-class therapeutics against fibrotic, neovascular and/or neoplastic disorders.
Our unique model combines smart use of capital, cross-fertilization, exponential value creation and diversification. LBV team is composed of seasoned multi-disciplinary drug developers and deal makers with proven record.

Landmark Bioventures Unique Model

Completely building Biotech Start-ups
from scratch in a lean and cost-effective way

Creating a diversified nexus of new ventures with a focus on fibrotic neovascular and/or neoplastic disorders 

 Developing first-in-class medecines combining cross-fertlization and exponential value creation

Diversified Nexus of New Biotech Ventures 

logo Elikya.png
Logo SPIMA.png

Founders & Partners

Zaki Photo.png

Zaki Sellam

Co-Founder & CEO

  • Grey LinkedIn Icon

• 20+ years of experience in Biotech

• Expert in Immuno-Oncology Drug Development

• Involved in multiple start-ups & more than 40 Deals

• Strong CRO and Academic network

• Board Member of Swiss Healthcare Licensing Group & Basel BioValley Association

Gary Photo-2.jpg

Gary Brandam

Co-Founder & COO


  • Grey LinkedIn Icon
  • 12+ years of experience in Biotech and Pharma

  • Led development of 4 program in oncology start-ups

  • Strong expertise in l commercialization of Oncology and Rare Disease assets

  • Expert in launch excellence in oncology and rare disease

Jacques Photo_2.png

Jacques Bauer

Co-Founder & CDO

  • Grey LinkedIn Icon
  • 35+ years of experience in Biopharma

  • Scientist, medicinal chemist and biologist

  • Former R&D Director at OM Pharma

  • Expert in drug discovery, drug development in oncology, immunology and metabolic diseases

  • Strong expertise in intellectual property

Mehdi Photo.png

Mehdi Chelbi

Co-Founder & CBO


  • Grey LinkedIn Icon
  • 20+ years of experience in in Biotech, Pharma and CROs

  • Entrepreneur and C-Level positions

  • Expert in corporate development and fundraising

  • Strong expertise in Preclinical and clinical development execution

  • Involved in the design, planning and setup of 300+ trials

Samson Fung

Co-Founder & CMO


  • Grey LinkedIn Icon
  • 30+ years of experience in Biotech and Pharma

  • Physician by training in oncology and hematology

  • Former CEO of Volvox Therapeutics

  • Expert in clinical development, medical affairs market access 

  • Spent 15+ years in pharma including Roche, Novartis, Novo Nordisk and Astra Zeneca

JPEG format LBV.jpg

Bernouillistrasse 20
Basel CH-4056

bottom of page